London, United Kingdom

Enriko Klootwijk

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2013-2021.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Bethesda, MD (US) (2013)
  • London, GB (2015 - 2021)

Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Enriko Klootwijk: Innovator in Therapeutic Agents

Introduction

Enriko Klootwijk is a notable inventor based in London, GB. He has made significant contributions to the field of therapeutic agents, particularly in the treatment of kidney and muscle dysfunction. With a total of 4 patents to his name, Klootwijk's work is recognized for its potential impact on healthcare.

Latest Patents

Klootwijk's latest patents include innovative compositions and methods that utilize N-acetyl mannosamine as a therapeutic agent. This invention focuses on treating kidney and muscle dysfunction by employing therapeutic amounts of N-acetyl mannosamine. His research aims to provide new solutions for patients suffering from these conditions.

Career Highlights

Enriko Klootwijk is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this prestigious institution allows him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Klootwijk's notable coworkers include Marjan Huizing and William A Gahl. Their collaborative efforts enhance the research environment and foster innovation in therapeutic solutions.

Conclusion

Enriko Klootwijk's work in developing therapeutic agents showcases his commitment to improving healthcare outcomes. His patents and collaborations reflect a dedication to advancing medical science and providing new treatment options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…